|
OMIM |
Link |
Information gain |
01 |
|
reticuloendotheliosis, x-linked
|
[NCBI]
|
0.00114043
|
|
|
AVP
|
[NCBI]
|
0.000971825
|
|
|
necrotizing encephalopathy, acute, autosomal dominant
|
[NCBI]
|
0.00092257
|
|
|
TNF
|
[NCBI]
|
0.000919592
|
|
|
ectodermal dysplasia, absent dermatoglyphic pattern, changes in nails, and simian crease
|
[NCBI]
|
0.000840405
|
|
|
FMF
|
[NCBI]
|
0.000838809
|
|
|
indifference to pain, congenital, autosomal dominant
|
[NCBI]
|
0.000787083
|
|
|
ETL2
|
[NCBI]
|
0.000600386
|
|
|
FEB1
|
[NCBI]
|
0.000587372
|
|
|
neutrophilic dermatosis, acute febrile
|
[NCBI]
|
0.000564232
|
|
|
periodic fever, familial, autosomal dominant
|
[NCBI]
|
0.000475273
|
|
|
HIDS
|
[NCBI]
|
0.000347374
|
|
|
FCAS
|
[NCBI]
|
0.000311545
|
|
|
MHS1
|
[NCBI]
|
0.000266778
|
|
|
muckle-wells syndrome
|
[NCBI]
|
0.000120533
|
|
|
kawasaki disease
|
[NCBI]
|
0.000120533
|
|
|
pelger-huet-like anomaly and episodic fever with abdominal pain
|
[NCBI]
|
0.000108917
|
|
|
insensitivity to pain with hyperplastic myelinopathy
|
[NCBI]
|
0.000108917
|
|
|
mental retardation, keratoconus, febrile seizures, and sinoatrial block
|
[NCBI]
|
0.000108917
|
|
|
MVK
|
[NCBI]
|
0.000105745
|
|
|
ED1
|
[NCBI]
|
8.03217e-05
|
|
|
TNFRSF1A
|
[NCBI]
|
7.84288e-05
|
|
|
crisponi syndrome
|
[NCBI]
|
7.8001e-05
|
|
|
majeed syndrome
|
[NCBI]
|
7.25122e-05
|
|
|
temporal arteritis
|
[NCBI]
|
7.24056e-05
|
|
|
CRH
|
[NCBI]
|
6.76953e-05
|
|
|
native american myopathy
|
[NCBI]
|
6.51912e-05
|
|
|
CINCA
|
[NCBI]
|
6.24962e-05
|
|
|
familial mediterranean fever, autosomal dominant
|
[NCBI]
|
6.24962e-05
|
|
|
FCDT
|
[NCBI]
|
6.0192e-05
|
|
|
MBL2
|
[NCBI]
|
5.64419e-05
|
|
|
DFNB9
|
[NCBI]
|
5.63945e-05
|
|
|
RA
|
[NCBI]
|
5.53498e-05
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
5.2001e-05
|
|
|
HSCR1
|
[NCBI]
|
5.13727e-05
|
|
|
SLC17A8
|
[NCBI]
|
4.98827e-05
|
|
|
synovitis, granulomatous, with uveitis and cranial neuropathies
|
[NCBI]
|
4.75766e-05
|
|
|
FHM2
|
[NCBI]
|
4.57605e-05
|
|
|
TTDP
|
[NCBI]
|
4.49264e-05
|
|
|
CIPA
|
[NCBI]
|
4.49264e-05
|
|
|
B2M
|
[NCBI]
|
4.21073e-05
|
|
|
HNA
|
[NCBI]
|
4.19792e-05
|
|
|
PTGER3
|
[NCBI]
|
4.13363e-05
|
|
|
PTGES
|
[NCBI]
|
4.13363e-05
|
|
|
sudden infant death syndrome
|
[NCBI]
|
4.00898e-05
|
|
|
MATN1
|
[NCBI]
|
3.8841e-05
|
|
|
MAP4
|
[NCBI]
|
3.8841e-05
|
|
|
EPHX2
|
[NCBI]
|
3.8841e-05
|
|
|
CEACAM5
|
[NCBI]
|
3.88153e-05
|
|
|
CRLF1
|
[NCBI]
|
3.52078e-05
|
|
|
LPIN2
|
[NCBI]
|
3.37993e-05
|
|
|
SMEI
|
[NCBI]
|
3.34866e-05
|
|
|
GABRG2
|
[NCBI]
|
3.25699e-05
|
|
|
BTK
|
[NCBI]
|
3.22381e-05
|
|
|
SJS1
|
[NCBI]
|
3.1697e-05
|
|
|
SLE
|
[NCBI]
|
3.06483e-05
|
|
|
NLRP3
|
[NCBI]
|
2.96118e-05
|
|
|
HNPP
|
[NCBI]
|
2.89466e-05
|
|
|
MB
|
[NCBI]
|
2.78547e-05
|
|
|
OTOF
|
[NCBI]
|
2.67089e-05
|
|
|
IPF1
|
[NCBI]
|
2.61037e-05
|
|
|
IBD1
|
[NCBI]
|
2.3879e-05
|
|
|
VEGF
|
[NCBI]
|
2.31088e-05
|
|
|
SLC18A2
|
[NCBI]
|
2.19235e-05
|
|
|
ERCC2
|
[NCBI]
|
2.15575e-05
|
|
|
PRL
|
[NCBI]
|
2.00952e-05
|
|
|
CCK
|
[NCBI]
|
1.90816e-05
|
|
|
C3
|
[NCBI]
|
1.90664e-05
|
|
|
CF
|
[NCBI]
|
1.87755e-05
|
|
|
HMGB1
|
[NCBI]
|
1.82869e-05
|
|
|
PGK1
|
[NCBI]
|
1.82869e-05
|
|
|
CDLS1
|
[NCBI]
|
1.78417e-05
|
|
|
UCP3
|
[NCBI]
|
1.73452e-05
|
|
|
NPY
|
[NCBI]
|
1.64838e-05
|
|
|
CSF3
|
[NCBI]
|
1.61015e-05
|
|
|
IP
|
[NCBI]
|
1.5664e-05
|
|
|
EGFR
|
[NCBI]
|
1.55177e-05
|
|
|
CCL2
|
[NCBI]
|
1.48501e-05
|
|
|
STAT5A
|
[NCBI]
|
1.42118e-05
|
|
|
OXT
|
[NCBI]
|
1.40598e-05
|
|
|
EIG
|
[NCBI]
|
1.40076e-05
|
|
|
AD
|
[NCBI]
|
1.37672e-05
|
|
|
KLK3
|
[NCBI]
|
1.36847e-05
|
|
|
IL2
|
[NCBI]
|
1.31454e-05
|
|
|
UCP2
|
[NCBI]
|
1.26801e-05
|
|
|
GFAP
|
[NCBI]
|
1.26794e-05
|
|
|
LEPR
|
[NCBI]
|
1.21896e-05
|
|
|
SLPI
|
[NCBI]
|
1.07847e-05
|
|
|
CHS
|
[NCBI]
|
1.06816e-05
|
|
|
antithrombin iii deficiency
|
[NCBI]
|
9.77579e-06
|
|
|
PWS
|
[NCBI]
|
9.72255e-06
|
|
|
ILK
|
[NCBI]
|
9.44196e-06
|
|
|
PMCH
|
[NCBI]
|
9.12359e-06
|
|
|
HDC
|
[NCBI]
|
7.6648e-06
|
|
|
IFNA1
|
[NCBI]
|
7.5418e-06
|
|
|
ADA
|
[NCBI]
|
7.50413e-06
|
|
|
lymphoma, non-hodgkin, familial
|
[NCBI]
|
7.0539e-06
|
|
|
TH
|
[NCBI]
|
6.57969e-06
|
|
|
AFP
|
[NCBI]
|
5.56617e-06
|
|
|
AS
|
[NCBI]
|
5.15202e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
3.92512e-06
|
|
|
ACHE
|
[NCBI]
|
3.78638e-06
|
|
|
STAT3
|
[NCBI]
|
3.66106e-06
|
|
|
GHRH
|
[NCBI]
|
3.63276e-06
|
|
|
BDNF
|
[NCBI]
|
2.56148e-06
|
|
|
HP
|
[NCBI]
|
1.72432e-06
|
|
|
SLC6A3
|
[NCBI]
|
1.62022e-06
|
|
|
POMC
|
[NCBI]
|
1.56288e-06
|
|
|
GAPDH
|
[NCBI]
|
1.50705e-06
|
|
|
CNTF
|
[NCBI]
|
1.4527e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.41532e-06
|
|
|
GNRH1
|
[NCBI]
|
1.36103e-06
|
|
|
TLR4
|
[NCBI]
|
1.16712e-06
|
|
|
ALB
|
[NCBI]
|
9.73008e-07
|
|
|
SOD2
|
[NCBI]
|
9.42967e-07
|
|
|
MPO
|
[NCBI]
|
8.23217e-07
|
|
|
EPO
|
[NCBI]
|
8.19845e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
5.77713e-07
|
|
|
G6PD
|
[NCBI]
|
3.26446e-07
|
|
|
HBB
|
[NCBI]
|
8.3176e-10
|
|